Cytokinetics Presents Positive Results From Cohort 4 of REDWOOD-HCM and Long-Term Results From FOREST-HCM - Benzinga

1 min to read

Cytokinetics Presents Positive Results From Cohort 4 of REDWOOD-HCM and Long-Term Results From FOREST-HCM – Benzinga

Ribbon Acquisition Corp Prices $50 Million Initial Public Offering

New York, New York, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Ribbon Acquisition Corp, a blank check company incorporated in the...
Ribbon Acquisition Corp Announces Closing of $50 Million Initial Public Offering.

New York, New York, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Ribbon Acquisition Corp (NASDAQ: RIBBU, the “Company”) today announced the...
ISS, Glass Lewis and BlackRock Issue 2025 Voting Guidelines

As companies begin preparing for the 2025 proxy season, Institutional Shareholder Services Inc. (ISS) and Glass Lewis, the leading providers...
D. Boral Capital Served as the Sole Underwriter on the IPO of BurTech Acquisition Corp (Nasdaq: BRKH) which Recently Completed an ~$894 Million Business Combination with Blaize, Inc. (“Blaize”)

WASHINGTON and EL DORADO HILLS, Calif., Jan. 15, 2025 (GLOBE NEWSWIRE) -- BurTech Acquisition Corp. (“BurTech”) (NASDAQ: BRKH), a publicly...
A New Generation of SPACs Leads the Way Into 2025

After a two-and-a-half-year lull in SPAC activity, the second half of 2024 brought glimmers of sunshine to the otherwise gloomy...